• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Acute Graft Versus Host Disease

Acute Graft Versus Host Disease - 162 Studies Found

Completed : Safety Follow-up of Treatment With Remestemcel-L in Pediatric Patients Who Have Failed to Respond to Steroid Treatment for Acute GVHD
: Grades B-D Acute Graft Versus Host Disease
: 2015-11-03
Terminated : Dose-finding Study Using Pentostatin for Injection in the Treatment of Steroid-refractory aGvHD
: Acute Graft Versus Host Disease
: 2002-04-02
: Drug: pentostatin for injection
Active, not recruiting : Infliximab and Basiliximab for Treatment of Steroid Refractory Acute Graft Versus Host Disease
:
  • Graft Versus Host Disease
  • Steroid Refractory GVHD
  • : 2011-12-01
    : Drug: Infliximab and Basiliximab Participants in this rese
Terminated : Intra Arterial (IA) Steroids Infusion for Hepatic Acute Hepatic Graft Versus Host Disease (aGVHD)
: Acute Graft Versus Host Disease
: 2010-06-09
: Drug: Methylprednisolone (Intra-arterial continuous infusion of corticosteroids) Sedation/anesthesia of
Completed : Markers of Inflammation in Hematopoietic Stem Cell Transplant
: Acute Graft Versus Host Disease
: 2007-12-21
Withdrawn : Methylprednisolone Sodium Succinate in Treating Patients With Acute Graft-versus-Host Disease of the Gastrointestinal Tract
:
  • Acute Graft Versus Host Disease
  • Intestinal Graft Versus Host Di
    : 2015-04-15
    :
    • Drug: Budesonide Given PO

Completed : Exploratory Safety Study of ALD518 in Subjects With Steroid-refractory Acute Graft Versus Host Disease (GVHD)
: Acute GvHD
: 2012-02-06
:
  • Biological: ALD518 160 mg IV q

Terminated : A Phase 2a Study of ALXN1007 in Subjects With Newly Diagnosed Acute GI GVHD
:
  • Acute Graft-versus-host Disease
  • GIGVHD

: 2014-09-17
:
  • Biological: ALXN1007 8 IV dose

Completed : A Study to Evaluate Steroid-free Treatment for Standard-Risk aGVHD (BMT CTN 1501)
: Acute GVHD
: 2016-06-08
:
  • Drug: Sirolimus Sirolimus will

Completed : Graft-Versus-Host Disease (GVHD) Prophylaxis After Allogeneic Peripheral Blood Hematopoietic Cell Transplantation
: Acute Graft Versus Host Disease
: 2008-12-04
:
  • Drug: Tacrolimus (TAC) Tacroli

<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.